Kyprolis 60 mg

Kyprolis 60 mg is a medicine authorised by Swissmedic under authorisation number 65690. The authorisation holder is Amgen Switzerland AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 23 November 2015 and the authorisation is valid without a time limit. ATC code L01XG02 places the medicine in the group Antineoplastic agents.

  • Dispensing category A
  • Authorisation number 65690
  • ATC L01XG02
  • Synthetic medicines
Authorisation data
Authorisation number65690
NameKyprolis 60 mg
Full nameKyprolis 60 mg, Pulver zur Herstellung einer Infusionslösung
Authorisation holderAmgen Switzerland AG
Medicinal product codeSynthetic medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeL01XG02
First authorisation23 November 2015
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Kyprolis 60 mg, Pulver zur Herstellung einer InfusionslösungA23 November 2015
2Kyprolis 10 mg, Pulver zur Herstellung einer InfusionslösungA24 January 2017
3Kyprolis 30 mg, Pulver zur Herstellung einer InfusionslösungA24 January 2017

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11Durchstechflasche(n)L01XG0207.16.1.A
21Durchstechflasche(n)L01XG0207.16.1.A
31Durchstechflasche(n)L01XG0207.16.1.A

Scroll the table sideways

Other medicines from this authorisation holder

Frequently asked questions

Is Kyprolis 60 mg authorised in Switzerland?

Yes. Kyprolis 60 mg is authorised by Swissmedic under authorisation number 65690, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Kyprolis 60 mg have?

Kyprolis 60 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Kyprolis 60 mg?

The authorisation holder is Amgen Switzerland AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com